Clinical Trial Update: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy [Phase 2]

View source ↗

Summary

This is a Phase 2 trial comparing venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Cusatuzumab (cusatuzumab)
• Venetoclax (venetoclax)

Snippet

Sponsor: OncoVerity, Inc. | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: RECRUITING